Skip to content
★ Sign in to follow
AL

Allan L. Goldstein

Board Director
Director
Regenerx Biopharmaceuticals Inc
Total declarations
21
Company
1
▲ Purchases (1 ops.)
€21k
▼ Sales (0 ops.)
—

Latest filing published 02 Mar 2022 for Regenerx Biopharmaceuticals INC.

Filing timeline

BuySale
Allan L. Goldstein

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Allan L. Goldstein: trading record in brief

Allan L. Goldstein (board member) discloses dealings in Regenerx Biopharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 21 December 2005 to 8 December 2021, the count stands at 21 filings.

Every open-market trade on record is a purchase: 1 purchase worth €21k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant.

The record was last updated on 2 March 2022 with a transaction in Regenerx Biopharmaceuticals Inc. The last insider purchase was made public on 6 July 2021, 1,952 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Allan L. Goldstein

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations21 total

21 of 21 declarations